Skip to main content

5-HT3 Receptors in the Central Nervous System

  • Chapter
Book cover Serotonin

Abstract

The presence of 5-HT3 receptor-mediated responses in peripheral tissues is well established. Their presence in the CNS is implied by the powerful behavioural effects produced by 5-HT3 receptor antagonists in laboratory animals (Costall et al., 1987a, b; Jones et al., 1987, 1988; Tyers et al., 1987). However, despite the high selectivity of action of these compounds for the 5-HT3 receptor, there is no direct evidence that 5-HT3 receptors are present in the brain. Three series of experiments have been conducted to address this issue: functional studies on central 5-HT pathways; effects on mesolimbic dopamine metabolism; and binding studies with a novel [3H]-labelled 5-HT3 receptor antagonist.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 74.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Butler, A., Hill, J. M., Ireland, S. J. and Tyers, M. B. (1988). Pharmacological properties of GR 38032F, a novel antagonist at 5-HT3 receptors. Br. J. Pharmacol., 94, 397–412.

    Google Scholar 

  • Costall, B., Domeney, A. M., Kelly, M. E., Naylor, R. J. and Tyers, M. B. (1987a). The antipsychotic potential of GR 38032F, a selective antagonist of 5-HT3receptors in the central nervous system. Br. J. Pharmacol., 90, 89P

    Google Scholar 

  • Costall, B., Domeney, A. M., Naylor, R. J. and Tyers, M. B. (1987b). Effects of the 5-HT3 receptor antagonist, GR 38032F, on raised dopaminergic activity in the mesolimbic system of the rat and marmoset brain. Br. J. Pharmacol., 92, 881–894

    Google Scholar 

  • Costall, B., Hendrie, C. A., Kelly, M. E. and Naylor, R. J. (1987c). Actions of sulpiride and tiapride in a simple model of anxiety in mice. Neuropharmacology, 26, 195–200

    Google Scholar 

  • Elliott, P., Alpert, J. E., Bannon, M. J. and Iversen, S. D. (1986). Selective activation of mesolimbic and mesocortical dopamine metabolism in rat brain by infusion of a stable substance P analogue into the ventral tegmental area. Brain Res., 363, 145–147

    Google Scholar 

  • Fake, C. S., King, F. D. and Sanger, G. J. (1987). BRL 43694: a potent and novel 5-HT3 receptor antagonist. Br. J. Pharmacol., 91, 335P

    Google Scholar 

  • Fozard, J. R. (1984). MDL 72222: a potent and highly selective antagonist at neuronal 5-hydroxytryptamine receptors. Naunyn-Schmiedeberg’s Arch. Pharmacol., 326, 36–44

    Google Scholar 

  • Hagan, R. M., Butler, A., Hill, J. M., Jordan, C. C., Ireland, S. J. and Tyers, M. B. (1987). Effect of the 5-HT3 receptor antagonist GR 38032F, on responses to injection of a neurokinin agonist into the ventral tegmental area of the rat brain. Eur. J. Pharmacol., 138, 303–305

    Google Scholar 

  • Ireland, S. J. and Tyers, M. B. (1987). Pharmacological characterisation of 5-hydroxytryptamine-induced depolarisation of the rat isolated vagus nerve. Br. J. Pharmacol., 90, 229–238

    Google Scholar 

  • Jones, B. J., Oakley, N. R. and Tyers, M. B. (1987). The anxiolytic activity of GR 38032F, a 5-HT3 receptor antagonist, in the rat and Cynomolgus monkey. Br. J. Pharmacol., 90, 88P

    Google Scholar 

  • Jones, B. J., Costall, B., Domeney, A. M., Kelly, M. E., Naylor, R. J., Oakley, N. R. and Tyers, M. B. (1988). The potential anxiolytic activity of GR 38032F, a 5-HT3 receptor antagonist. Br. J. Pharmacol., 93, 985–993

    Google Scholar 

  • Kilpatrick, G. J., Jones, B. J. and Tyers, M. B. (1987). Identification and distribution of 5-HT3 receptors in rat brain using radioligand binding. Nature, 330, 746–748

    Google Scholar 

  • Peroutka, S. J. and Snyder, S. H. (1979). Multiple serotonin receptors: differential binding of [3H]-5-hydroxytryptamine, [3H]-lysergic acid diethylamide and [3H]-spiroperidol. Mol. Pharmacol., 16, 687–699

    Google Scholar 

  • Peroutka, S. J., Lebovitz, R. M. and Snyder, S. H. (1981). Two distinct central serotonin receptors with different physiological functions. Science, 212, 827–829

    Google Scholar 

  • Richardson, B. P., Engel, G., Donatsch, P. and Stadler, P. A. (1985). Identification of serotonin M-receptor subtypes and their specific blockade by a new class of drugs. Nature, 316, 126–131

    Google Scholar 

  • Tyers, M. B., Costall, B., Domeney, A. M., Jones, B. J., Kelly, M. E., Naylor, R. J. and Oakley, N. R. (1987). The anxiolytic activities of 5-HT3 antagonists in laboratory animals. Neurosci. Lett., Suppl. 29, S68

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Copyright information

© 1989 The editors and contributors

About this chapter

Cite this chapter

Tyers, M.B., Costall, B., Naylor, R.J. (1989). 5-HT3 Receptors in the Central Nervous System. In: Mylecharane, E.J., Angus, J.A., de la Lande, I.S., Humphrey, P.P.A. (eds) Serotonin. Satellite Symposia of the IUPHAR 10th International Congress of Pharmacology. Palgrave Macmillan, London. https://doi.org/10.1007/978-1-349-10114-6_12

Download citation

Publish with us

Policies and ethics